- ATOMY Singapore - chineză - HSA (Health Sciences Authority)

- atomy

international advanced bio-pharmaceutical industries pte. ltd. - 液体筹备工作(内部使用的)

KOREAN RED GINSENG SPHERICAL GRANULE ATOMY Singapore - chineză - HSA (Health Sciences Authority)

korean red ginseng spherical granule atomy

international advanced bio-pharmaceutical industries pte. ltd. - 颗粒剂(内部使用的)

牛樟芝 - Singapore - chineză - HSA (Health Sciences Authority)

牛樟芝 -

international advanced bio-pharmaceutical industries pte. ltd. - 胶囊

牛樟芝 - Singapore - chineză - HSA (Health Sciences Authority)

牛樟芝 -

international advanced bio-pharmaceutical industries pte. ltd. - 胶囊

牛樟芝 - Singapore - chineză - HSA (Health Sciences Authority)

牛樟芝 -

international advanced bio-pharmaceutical industries pte. ltd. - 胶囊

补助提御素 - Singapore - chineză - HSA (Health Sciences Authority)

补助提御素 -

international advanced bio-pharmaceutical industries pte. ltd. - 粉剂(内部使用的)

牛樟芝精液 - Singapore - chineză - HSA (Health Sciences Authority)

牛樟芝精液 -

international advanced bio-pharmaceutical industries pte. ltd. - 液体筹备工作(内部使用的)

痛舒適 Taiwan - chineză - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

痛舒適

緯曜國際股份有限公司 彰化縣彰化市香山里彰南路二段346巷12號 (24260602) - methoxyflurane - 吸入用液劑 - 主成分 () ; methoxyflurane (2804000900) % - methoxyflurane - 適用於輕至中度急性疼痛的短期止痛

美加柔持續性藥效膜衣錠50毫克 Taiwan - chineză - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

美加柔持續性藥效膜衣錠50毫克

西海生技股份有限公司 臺北市中山區民權東路二段46號10樓之2 (27770261) - quetiapine fumarate - 持續性藥效膜衣錠 - quetiapine fumarate (9200037620) (equivalent to quetiapine.....50mg)mg - quetiapine - 治療思覺失調症、雙極性疾患的鬱症發作、躁症發作或混合發作。對於抗鬱劑單一藥物治療效果不佳的重鬱症(mdd)病人,可作為重鬱症發作的附加治療。開始治療之前,臨床醫師應該考慮quetiapine xr的安全性。

美加柔持續性藥效膜衣錠200毫克 Taiwan - chineză - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

美加柔持續性藥效膜衣錠200毫克

西海生技股份有限公司 臺北市中山區民權東路二段46號10樓之2 (27770261) - quetiapine fumarate - 持續性藥效膜衣錠 - quetiapine fumarate (9200037620) (equivalent to quetiapine.....200mg)mg - quetiapine - 治療思覺失調症、雙極性疾患的鬱症發作、躁症發作或混合發作。對於抗鬱劑單一藥物治療效果不佳的重鬱症(mdd)病人,可作為重鬱症發作的附加治療。開始治療之前,臨床醫師應該考慮quetiapine xr的安全性。